Skip to main content

Tidal Investments LLC

Position in ABBV — AbbVie Inc.

CIK 1600064 MILWAUKEE, WI

Position in ABBV

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$108,298,491
+$62,577,186 QoQ
Shares Held
497,947
+148.8% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.41379303419842.ToString("F0")% Shared 0.5862069658015813.ToString("F0")% None 0.ToString("F0")%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Derivatives in ABBV

reported options exposure · as of Dec 31, 2025
CallValue
$251,339
CallShares
1,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Tidal Investments LLC holds $1,050,650,050 across 16 Drug Manufacturers - General names. ABBV ranks #4 (10.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 ABBV
AbbVie Inc.
This page
497,947 $108,298,491

All Filings in ABBV

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $108,298,491 497,947
2025-12-31 $45,721,305 200,102
2025-12-31 $251,339 1,100
2025-09-30 $37,883,880 163,617
2025-06-30 $25,873,385 139,389
2025-03-31 $27,211,410 129,875
2024-12-31 $24,121,353 135,742
2024-12-31 $355 2
2024-09-30 $22,389,295 113,375
2024-06-30 $19,312,293 112,595
2024-03-31 $18,215,279 100,029
2023-12-31 $10,411,504 67,184
2023-09-30 $11,499,680 77,148
2023-06-30 $9,895,918 73,450
2023-03-31 $10,533,560 66,095
2022-12-31 $12,299,651 76,107
2022-09-30 $9,912,884 73,861
2022-06-30 $10,594,077 69,170
2022-03-31 $11,155,437 68,814
2021-12-31 $7,571,161 55,917
2021-09-30 $5,204,296 48,246
2021-06-30 $3,244,933 28,808
2021-03-31 $1,847,856 17,075
2020-12-31 $1,234,046 11,517
2020-09-30 $646,939 7,386
2020-06-30 $626,388 6,380
2020-03-31 $321,674 4,222